Jiaxin Wu

Title: Jiaxin Wu: Innovator in Pharmaceutical Chemistry

Introduction

Jiaxin Wu is a prominent inventor based in Anhui, China. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel inhibitors for various kinases. With a total of 3 patents, his work focuses on addressing critical medical conditions through innovative compounds.

Latest Patents

One of his latest patents is titled "Inhibitor of FLT3 kinase and use thereof." This invention provides a novel inhibitor of FLT3 kinase, comprising a compound of formula (I) or a pharmaceutically acceptable salt, solvate, isomer, ester, acid, metabolite, or prodrug thereof. The patent also includes a pharmaceutical composition comprising the compound of formula (I), along with methods for preventing or treating FLT3-related conditions, especially those related to the mutant FLT3 kinase, particularly the FLT3/ITD mutant kinase.

Another significant patent is the "EGFR and ALK dual inhibitor." This application presents a compound of formula I, which serves as a dual inhibitor for EGFR and ALK. It can be utilized alone or in combination with other therapeutic agents to treat diseases such as non-small cell lung cancer. The compounds are particularly useful in treating diseases associated with various mutations of the EGFR and ALK genes, making them valuable in the first-line treatment of ALK-positive late-stage non-small cell lung cancer.

Career Highlights

Jiaxin Wu has worked with notable organizations, including Precedo Pharmaceuticals Co., Ltd and the Chinese Academy of Sciences. His experience in these institutions has allowed him to advance his research and contribute to the development of innovative pharmaceutical solutions.

Collaborations

Throughout his career, Jiaxin Wu has collaborated with esteemed colleagues, including Qingsong Liu and Jing Liu. These partnerships have fostered a collaborative environment that enhances the research and development of new therapeutic agents.

Conclusion

Jiaxin Wu's contributions to pharmaceutical chemistry through his innovative patents demonstrate his commitment to advancing medical science. His work in developing inhibitors for critical kinases showcases the potential for new treatments in oncology and other fields.